| Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
|---|
| 02/13/2002 | EP1019726B1 Prevention of sudden infant death |
| 02/13/2002 | EP0830142B1 Prrs (porcine reproductive and respiratory syndrome) virus vaccine |
| 02/13/2002 | EP0703786B1 Use of nona- and decapeptides in the preparation of a drug for the treatment of aids |
| 02/13/2002 | EP0693925B1 Production of a recombinant factor xa inhibitor of leech hirudo medicinalis |
| 02/13/2002 | EP0630257B1 Thymus-derived, immune-enhancing agent for therapeutic use in immunocompromised hosts |
| 02/13/2002 | EP0594795B1 Michellamines useful as antiviral agents, composition and method of treatment |
| 02/13/2002 | CN1335853A Alpha v beta b integrin inhibitors |
| 02/13/2002 | CN1335849A Pyrrolopyrimidines as protein kinase inhibitors |
| 02/13/2002 | CN1335843A Thiourea inhibitors of herpes viruses |
| 02/13/2002 | CN1335842A Process to prepare cyclic-sulfur fluorine containing oxazolidinones |
| 02/13/2002 | CN1335841A N-(iminomethyl) amine derivatives, their preparation, their use as medicines and compositions containing them |
| 02/13/2002 | CN1335834A Aromatic heterocycle compounds having HIV integrase inhibiting activities |
| 02/13/2002 | CN1335771A N-ureidoalkyl-piperidines as modulators of chemokine receptor activity |
| 02/13/2002 | CN1335301A 3-cyano-2,4,5-trifluoro-benzoic acid and its derivant and their application |
| 02/13/2002 | CN1335181A Antifungal medicine synergist and its prepn and application |
| 02/13/2002 | CN1335163A Chinese medicine for treating cold and cough |
| 02/13/2002 | CN1335156A Tuberculosis-treating medicine powder compounding process |
| 02/13/2002 | CN1335145A External-use plaster for softening dry feces and dissipating mass |
| 02/13/2002 | CN1335139A Compounding process of pain relieving and inflammation diminishing ointment |
| 02/13/2002 | CN1335132A Application of ornidazole in wide-spectrum antifungal medicine |
| 02/13/2002 | CN1335128A Onychomycosis treating medicine |
| 02/12/2002 | US6346611 High affinity TGfβ nucleic acid ligands and inhibitors |
| 02/12/2002 | US6346608 MecB |
| 02/12/2002 | US6346551 Antibacterial, antifungal, antiviral, bactericidal and/or sterilization agents, anticancer drugs, blood coagulation and fibrinolysis inhibitors and/or blocking agents, inhibitory and/or blocking agents of antigen-antibody reactions |
| 02/12/2002 | US6346533 Dissolving in solvent; low to high speed drying; high air pressure atomizing; reduced particle size; bioavailability |
| 02/12/2002 | US6346531 G-CSF mimetics |
| 02/12/2002 | US6346526 Carbapenicillin with 1,1-dioxo-2,3-dihydronaphtho(1,8-de)(1,2)thiazin-2-yl-substituent; treating staphylococcus infections resistant to methicillin; side effect reduction |
| 02/12/2002 | US6346525 Carbapenicillin with 1,1-dioxo-2h-1-thia-2,3-diaza-naphthalene substituent; treating staphylococcus infections resistant to methicillin; side effect reduction |
| 02/12/2002 | US6346422 Method of selecting bacterial strains |
| 02/12/2002 | US6346409 Tryptophenyl tRNA synthetase from Streptococcus pneumoniae |
| 02/12/2002 | US6346392 Amino acid sequence from streptococcus; drug screening of bactericides and bacteriostats |
| 02/12/2002 | US6346391 Treating infection by administering drug to which the microorganism is resistant and an inhibitor of an acrab-like efflux pump |
| 02/12/2002 | US6346375 NANBV diagnostics and vaccines |
| 02/12/2002 | US6346279 Antiseptics with phosphorous acid, anionic surfactants of alkylbenzenesulfonic acids and alkali or ammonium salts |
| 02/12/2002 | US6346252 Method of obtaining an antibacterial and/or antifungal extract from the algae, bonnemaisoniacea |
| 02/12/2002 | US6346247 Prevention and treatment of autoimmune disease with luminally administered polyclonal antibodies |
| 02/12/2002 | CA2131837C High molecular weight surface proteins of non-typeable haemophilus |
| 02/12/2002 | CA2024399C Compounds |
| 02/12/2002 | CA2018442C Antifungal 4-¬4-¬4-¬4-¬¬2-(2,4-difluorophenyl)-2-(1h-azolylmethyl)-1,3-dioxolan-4-yl|methoxy|phenyl|-1piperazinyl|triazolones and imidazolones |
| 02/11/2002 | CA2740282A1 Purification of hbv antigens for use in vaccines |
| 02/07/2002 | WO2002010764A2 SPECIFIC BINDING AGENTS FOR KSHV vIL-6 THAT NEUTRALIZE A BIOLOGICAL ACTIVITY |
| 02/07/2002 | WO2002010743A1 Improved anti-viral and anti-tumor chemotherapy by administration of erythropoeitin |
| 02/07/2002 | WO2002010416A1 IMPROVED VIRUS LIKE PARTICLES BASED ON SMALL ENVELOPE PROTEIN FROM HEPATITIS B (HBsAg-S) |
| 02/07/2002 | WO2002010393A2 Isolated nucleic acid molecules which encode t cell inducible factors, or interleukin-21, the proteins encoded, and uses thereof |
| 02/07/2002 | WO2002010387A2 G-protein coupled receptors |
| 02/07/2002 | WO2002010363A2 Protein phosphatases |
| 02/07/2002 | WO2002010353A1 Lipo-viro-particle complexes, preparation method and uses |
| 02/07/2002 | WO2002010343A2 Temperature-sensitive live vaccine for mycoplasma hyopneumoniae |
| 02/07/2002 | WO2002010339A2 Gene expression profile for kshv infection and methods for treating same |
| 02/07/2002 | WO2002010242A1 Polyurethane film-forming dispersions in alcohol-water system |
| 02/07/2002 | WO2002010216A2 Proteins and nucleic acids encoding same |
| 02/07/2002 | WO2002010192A2 Somatostatin analogues |
| 02/07/2002 | WO2002010181A1 Azithromocin monohydrate with lower hygroscopicity, preparation method and pharmaceutical compositions which include it |
| 02/07/2002 | WO2002010172A1 Azabicyclic compounds, preparation thereof and use as medicines, in particular as antibacterial agents |
| 02/07/2002 | WO2002010161A1 Process for preparing arylacetylaminothiazoles |
| 02/07/2002 | WO2002010157A1 Benzofuran derivatives and their use as antibacterial agents |
| 02/07/2002 | WO2002010156A1 Benzofuran derivatives and their use as antibacterial agents |
| 02/07/2002 | WO2002010148A1 Novel coumarin derivatives and the salts thereof, a process for the preparation thereof and their use in the pharmaceutical field |
| 02/07/2002 | WO2002010146A1 Carboxamide compounds and their use as antagonists of a human 11cby receptor |
| 02/07/2002 | WO2002010141A1 Imidazole derivatives |
| 02/07/2002 | WO2002010140A2 Imidazolyl derivatives |
| 02/07/2002 | WO2002010139A1 Hexahydro-7-1h-azepin-2-yl-haxanoic acid derivatives as inhibitors of inducible nitric oxide synthase |
| 02/07/2002 | WO2002010137A2 Indazole derivatives as jnk inhibitors |
| 02/07/2002 | WO2002009768A2 Therapeutic polyesters and polyamides |
| 02/07/2002 | WO2002009767A2 Therapeutic polyanhydride compounds for drug delivery |
| 02/07/2002 | WO2002009758A2 Inhibitors of cellular efflux pumps of microbes |
| 02/07/2002 | WO2002009753A1 Composition and method for the treatment or prevention of hiv infection |
| 02/07/2002 | WO2002009750A2 Vaccines for equine herpesvirus type-1: viruses harboring mutations within the immediate early gene |
| 02/07/2002 | WO2002009749A2 Respiratory syncytial virus vaccine |
| 02/07/2002 | WO2002009747A1 Method for preventing and curing diseases of an immune system and a remedy for carrying out said method |
| 02/07/2002 | WO2002009746A2 Vaccines comprising outer membrane vesciles from gram negative bacteria |
| 02/07/2002 | WO2002009724A1 Pharmaceutical compositions containing tobramycin and xanthan gum |
| 02/07/2002 | WO2002009706A1 Agonists of follicle stimulating hormone activity |
| 02/07/2002 | WO2002009699A2 Method of treating symptoms of common cold, allergic rhinitis and infections relating to the respiratory tract |
| 02/07/2002 | WO2002009696A1 Methods for treating cell proliferative disorders and viral infections |
| 02/07/2002 | WO2002009690A2 Pharmaceutical composition comprising a photochemotherapeutic agent and a mucoadhesive agent |
| 02/07/2002 | WO2002009688A1 Fatty acid synthase inhibitors |
| 02/07/2002 | WO2002009686A2 Cdc25 phosphatase inhibitors |
| 02/07/2002 | WO2002009678A2 Charged phospholipid compositions and methods for their use |
| 02/07/2002 | WO2002009677A2 Method to treat infectious diseases and/or to enhance antimicrobial efficacy of drugs |
| 02/07/2002 | WO2002009667A2 Dispersions for formulating slightly or poorly soluble active ingredients |
| 02/07/2002 | WO2002009651A2 Fatty acid synthase inhibitors |
| 02/07/2002 | WO2002009648A2 Antimicrobial biaryl compounds |
| 02/07/2002 | WO2002009643A2 Vaccines for broad spectrum protection against diseases caused by neisseria meningitidis |
| 02/07/2002 | WO2002009524A1 A new antibacterial composition comprising as an active ingredient saponificated vegetable oil |
| 02/07/2002 | WO2001085700A3 Hiv replication inhibiting pyrimidines and triazines |
| 02/07/2002 | WO2001081310A8 1-aroyl-piperidinyl benzamidines |
| 02/07/2002 | WO2001078773A3 Dissociated pili, their production and use |
| 02/07/2002 | WO2001078652A3 Methods for drug discovery, disease treatment, and diagnosis using metabolomics |
| 02/07/2002 | WO2001074811A3 Substituted 1,3-thiazole compounds, their production and use |
| 02/07/2002 | WO2001074787A3 Crystalline pharmaceutical |
| 02/07/2002 | WO2001057193A3 Protein c derivatives |
| 02/07/2002 | WO2001044294A3 Compositions and methods for inhibiting endothelial cell proliferation |
| 02/07/2002 | WO2001042449A3 Methods for introducing genes into mammalian subjects |
| 02/07/2002 | WO2001040240A3 Mono- and disaccharide derivatives |
| 02/07/2002 | WO2001032831A3 Screening and use of agents which block or activate intein splicing utilizing natural or homologous exteins |
| 02/07/2002 | WO2001030333A3 Tissue factor antagonists and methods of use thereof |
| 02/07/2002 | WO2001029233A3 Chimeric immunogenic compositions and nucleic acids encoding them |
| 02/07/2002 | WO2001002587A3 Novel antifungal agents and fungicides, method for the production thereof and their use |
| 02/07/2002 | US20020016976 Mutant multi-substrate enzyme which accepts at least one orthogonal substrate analog, whereby catalytic activity results in combination of all or part of orthogonal substrate with other substrate of enzyme; drug screening |